Simek I, Kubias K, Duda M
2nd Medical Clinic, Palacky University, Olomouc, Czechoslovakia.
Acta Physiol Hung. 1992;80(1-4):417-21.
The chymotrypsin in the stool test was used to monitor adequate enzymatic substitution in treating exocrine pancreatic insufficiency with 18 patients (16 suffering from chronic pancreatitis and 2 having passed duodenopancreatectomy due to pancreatic cancer). This test helps to identify pancreatic insufficiency and can be successfully used in monitoring the adequate amount of pancreatic substitute, which, we have found, differs from patient to patient. The dosage can be higher in cases of chronic pancreatitis than in those required after duodenopancreatectomy.
粪便检测中的胰凝乳蛋白酶被用于监测18例接受外分泌性胰腺功能不全治疗的患者（16例患有慢性胰腺炎，2例因胰腺癌接受十二指肠胰腺切除术）的酶替代治疗是否充分。该检测有助于识别胰腺功能不全，并可成功用于监测胰腺替代物的适当用量，我们发现，该用量因患者而异。慢性胰腺炎患者的用量可能高于十二指肠胰腺切除术后所需的用量。
